Resveratrol activates SIRT1 (deacetylase that mimics caloric restriction), AMPK (metabolic sensor), and NRF2 (antioxidant response element). In theory, this should produce: improved mitochondrial function, reduced inflammation, enhanced insulin sensitivity, and slower aging. In practice, oral bioavailability of 1-2% means plasma concentrations in humans are 100-1,000x lower than those used in cell and animal studies. The rapid conjugation to resveratrol-3-O-glucuronide and resveratrol-3-sulfate creates metabolites that may retain SOME biological activity but are much weaker than parent resveratrol. Pterostilbene (dimethylated resveratrol) avoids this metabolism due to methyl group protection.
No critical interactions identified at typical supplement doses.
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.